Jan 13, 2025 09:05AM
Jan 13, 2025 09:00AM
Jan 6, 2025 09:00AM
Jan 8, 2024 08:15AM
Jan 3, 2024 07:00AM
Oct 18, 2023 05:10AM
Jun 15, 2023 06:00AM Editas Medicine (EDIT) Prices 12.5M Share Offering at $10/sh
Jun 14, 2023 10:06PM
Jun 14, 2023 04:07PM
Jun 14, 2023 04:05PM
Jan 9, 2023 08:15AM
Jan 9, 2023 08:15AM
Jan 9, 2023 08:15AM
Jan 4, 2023 06:30AM Editas Medicine to Present at the 41st Annual J.P. Morgan Healthcare Conference
Jan 4, 2023 06:30AM
Jan 10, 2022 07:00AM
Jan 10, 2022 07:00AM
Jan 4, 2022 06:58AM
Jan 4, 2022 06:58AM
Feb 25, 2021 03:25PM
Jan 21, 2021 06:04AM Editas Medicine (EDIT) Prices 3.5M Share Common Offering at $66/Sh
Jan 20, 2021 10:30PM
Jan 20, 2021 10:30PM
Jan 19, 2021 04:03PM
Jan 19, 2021 04:01PM
Jan 19, 2021 04:01PM
Jan 19, 2021 09:27AM
Jan 11, 2021 06:11AM Editas Medicine (EDIT) Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conferenc
Jan 11, 2021 06:05AM
Jan 11, 2021 06:05AM
Jan 4, 2021 04:05PM
Jan 4, 2021 04:05PM
Aug 6, 2020 05:23PM
Aug 6, 2020 04:01PM
Aug 6, 2020 04:01PM Editas Medicine Regains Full Global Rights to Ocular Medicines
Jan 13, 2020 09:12AM
Jan 13, 2020 09:00AM
Jan 13, 2020 09:00AM
Jan 2, 2020 09:00AM
Jan 2, 2020 09:00AM
Jan 7, 2019 09:09AM
Jan 7, 2019 09:00AM Editas Medicine Reports on Recent Progress at J.P. Morgan Healthcare Conference
Jan 7, 2019 09:00AM
Jan 2, 2019 08:30AM
Jan 2, 2019 08:30AM
Mar 7, 2018 06:07AM
Feb 1, 2018 07:00AM
Jan 8, 2018 09:00AM
Jan 8, 2018 09:00AM Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at J.P. Morgan Healthcare Conference
Jan 3, 2018 08:57AM

276,561 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All